Intubated patients developing tracheobronchitis or pneumonia have distinctive complement system gene expression signatures in the pre-infection period: A pilot study

Medicina Intensiva

Volumn 36, Issue 4, 2012, Pages 257-263

  Martin Loeches, I ^a   Papiol, E ^b   Almansa, R ^c   Lopez Campos G ^d   Bermejo Martin, J F ^c   Rello, J ^b  

^a HOSPITAL DE SABADELL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Biomarker; Gene expression; Genes; RNA; Sepsis; VAP; VAT; Ventilator associated pneumonia; Ventilator associated tracheobronchitis

Indexed keywords

CALCIUM; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1QA; COMPLEMENT COMPONENT C1QB; COMPLEMENT COMPONENT C1QC; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3AR1; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C9; CYCLIC AMP; DECAY ACCELERATING FACTOR; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CALCIUM SIGNALING; CLINICAL ARTICLE; COMPLEMENT SYSTEM; COMPUTER PROGRAM; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; LEUKOCYTE COUNT; MALE; PILOT STUDY; PRE INFECTION PERIOD; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INTUBATION; TRACHEOBRONCHITIS; TRANSLATION REGULATION; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS;

BRONCHITIS; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; TRACHEITIS;

EID: 84860117833     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.10.009     Document Type: Article

References (26)

1. Rello J., Ausina V., Castella J., Net A., Prats G. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992, 102:525-529.
2. Craven D.E., Hjalmarson K.I. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Clin Infect Dis 2010, 51(Suppl. 1):S59-S66.
3. Craven D.E. Ventilator-associated tracheobronchitis (VAT): questions, answers, and a new paradigm?. Crit Care 2008, 12:157.
4. Dallas J., Skrupky L., Abebe N., Boyle W.A., Kollef M.H. Ventilator-Associated Tracheobronchitis (VAT) in a mixed surgical and medical ICU population. Chest 2010.
5. Nseir S., Di Pompeo C., Pronnier P., Beague S., Onimus T., Saulnier F. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002, 20:1483-14893.
6. Nseir S., Favory R., Jozefowicz E., Decamps F., Dewavrin F., Brunin G., et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care 2008, 12:R62. VAT Study Group.
7. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. American Thoracic Society, Infectious Diseases Society of America.
8. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994, 20:225-232.
9. Kollef M.H., Bock K.R., Richards R.D., Hearns M.L. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 1995, 122:743-748.
10. Delclaux C., Roupie E., Blot F., Brochard L., Lemaire F., Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med 1997, 156:1092-1098.
11. Ferreira V.P., Pangburn M.K., Cortés C. Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 2010, 47:2187-2197.
12. Morris J.A., Francois C., Olson P.K., Cotton B.A., Summar M., Jenkins J.M., et al. Genetic variation in complement component 2 of the classical complement pathway is associated with increased mortality and infection: a study of 627 patients with trauma. J Trauma 2009, 66:1265-1270.
13. Laarman A., Milder F., van Strijp J., Rooijakkers S. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. J Mol Med 2010, 88:115-120.
14. Walport M.J. Complement. First of two parts. N Engl J Med 2001, 344:1058-1066.
15. Duan B., Davis R., Sadat E.L., Collins J., Sternweis P.C., Yuan D., et al. Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice. J Immunol 2010, 185:335-344.
16. Conche C., Boulla G., Trautmann A., Randriamampita C. T cell adhesion primes antigen receptor-induced calcium responses through a transient rise in adenosine 3',5'-cyclic monophosphate. Immunity 2009, 30:33-43.
17. Fassbender M., Herter S., Holtappels R., Schild H. Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol. Med Microbiol Immunol 2008, 197:185-189.
18. Varga Z., Hajdu P., Panyi G. Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases. Immunol Lett 2010, 130:19-25.
19. Kummerow C., Junker C., Kruse K., Rieger H., Quintana A., Hoth M. The immunological synapse controls local and global calcium signals in T lymphocytes. Immunol Rev 2009, 231:132-147.
20. Korade-Mirnics Z., Corey S.J. Src kinase-mediated signaling in leukocytes. J Leukoc Biol 2000, 68:603-613.
21. Kollef M.H. Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia. Clin Infect Dis 2010, 51(Suppl. 1):S29-S35.
22. Craven D.E., Chroneou A., Zias N., Hjalmarson K.I. Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes. Chest 2009, 135:521-528.
23. Cobb J.P., Moore E.E., Hayden D.L., Minei J.P., Cuschieri J., Yang J., et al. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg 2009, 250:531-539.
24. McDunn J.E., Husain K.D., Polpitiya A.D., Burykin A., Ruan J., Li Q., et al. Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS One 2008, 3:e1564.
25. Kollef M.H., Afessa B., Anzueto A., Veremakis C., Kerr K.M., Margolis B.D., et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 300:805-813. NASCENT Investigation Group.
26. Koulenti D., Lisboa T., Brun-Buisson C., Krueger W., Macor A., Sole-Violan J., et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009, 37:2360-2368. EU-VAP/CAP Study Group.